1,3-dimethyl-5-((1-tosyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione

Names and Identifiers

Canonical SMILES: Cc1ccc(S(=O)(=O)n2cc(C=C3C(=O)N(C)C(=O)N(C)C3=O)c3ccccc32)cc1

Standard InChI: InChI=1S/C22H19N3O5S/c1-14-8-10-16(11-9-14)31(29,30)25-13-15(17-6-4-5-7-19(17)25)12-18-20(26)23(2)22(28)24(3)21(18)27/h4-13H,1-3H3

Standard InChI Key: OKDQQPUPIWSHAJ-UHFFFAOYSA-N

Molfile:

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    1.7923   -6.6839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7911   -7.5107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4993   -7.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4974   -6.2693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2154   -6.6800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2159   -7.5107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0063   -7.7654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4961   -7.0921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0055   -6.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2627   -5.6401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0688   -5.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6217   -6.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4247   -5.9121    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6816   -5.1289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1336   -4.5137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3242   -4.6815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3687   -6.8644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4884   -4.9611    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7733   -4.0707    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9758   -6.5274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3891   -3.7303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2645   -8.5493    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.6669   -9.2564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5109   -8.8861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0188   -8.2284    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2567   -9.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6584  -10.6671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4735  -10.6703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8852   -9.9611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4766   -9.2573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8862  -11.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  6  7  1  0
 12 17  2  0
  7  8  1  0
 14 18  2  0
  8  9  2  0
 16 19  2  0
  9  5  1  0
 13 20  1  0
  4  1  1  0
 15 21  1  0
  9 10  1  0
  7 22  1  0
  5  6  1  0
 22 23  1  0
 10 11  2  0
 22 24  2  0
 11 12  1  0
 22 25  2  0
 23 26  2  0
  2  3  1  0
 26 27  1  0
  3  6  2  0
 27 28  2  0
  1  2  2  0
 28 29  1  0
  5  4  2  0
 29 30  2  0
 30 23  1  0
 11 16  1  0
 28 31  1  0
M  END

Alternative Forms

Parent:

ALA466449
1,3-Dimethyl-5-[[1-(4-methylphenyl)sulfonylindol-3-yl]methylidene]-1,3-diazinane-2,4,6-trione

Associated Targets(Human)

RXF 393 (41971 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

UO-31 (46270 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 437.48	Molecular Weight (Monoisotopic): 437.1045	AlogP: 2.62	#Rotatable Bonds: 3
Polar Surface Area: 96.76	Molecular Species: ┄	HBA: 6	HBD: ┄
#RO5 Violations: ┄	HBA (Lipinski): 8	HBD (Lipinski): ┄	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: ┄	CX Basic pKa: ┄	CX LogP: 2.77	CX LogD: 2.77
Aromatic Rings: 3	Heavy Atoms: 31	QED Weighted: 0.46	Np Likeness Score: -1.31

References

1. Singh P, Kaur M, Verma P.. (2009) Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads., 19 (11): [PMID:19398334] [10.1016/j.bmcl.2009.04.014]

Source

Source(1):

Scientific Literature